FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
Authors
Keywords
FXR, Obetacholic acid, Bile acid, NAFLD, NASH, Alcoholic hepatitis
Journal
Current Atherosclerosis Reports
Volume 17, Issue 4, Pages -
Publisher
Springer Nature
Online
2015-02-17
DOI
10.1007/s11883-015-0500-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction
- (2014) Xijun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice
- (2014) F.A.R. Lívero et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice
- (2014) Rotonya M. Carr et al. PLoS One
- Bile Acids Reduce Endocytosis of High-Density Lipoprotein (HDL) in HepG2 Cells
- (2014) Clemens Röhrl et al. PLoS One
- Temporal Effects of Ethanol Consumption on Energy Homeostasis, Hepatic Steatosis, and Insulin Sensitivity in Mice
- (2013) Rotonya M. Carr et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
- (2013) Weibin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice
- (2013) Yan Lu et al. GUT
- Genetic Variation inNR1H4Encoding the Bile Acid Receptor FXR Determines Fasting Glucose and Free Fatty Acid Levels in Humans
- (2013) Martin Heni et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The TGR5 receptor mediates bile acid–induced itch and analgesia
- (2013) Farzad Alemi et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
- (2013) Xuelian Xiong et al. JOURNAL OF HEPATOLOGY
- Ageing Fxr Deficient Mice Develop Increased Energy Expenditure, Improved Glucose Control and Liver Damage Resembling NASH
- (2013) Mikael Bjursell et al. PLoS One
- Bile Acid-Mediated Control of Liver Triglycerides
- (2013) Claudia Fuchs et al. SEMINARS IN LIVER DISEASE
- Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
- (2012) Danielle A.A. Hollman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis
- (2012) Naoki Tanaka et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor
- (2012) Lieke M. van der Velden et al. HEPATOLOGY
- The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin
- (2012) Miao Hu et al. JOURNAL OF LIPID RESEARCH
- FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model
- (2012) Ulrich Deuschle et al. PLoS One
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Nutritional Regulation of Bile Acid Metabolism Is Associated with Improved Pathological Characteristics of the Metabolic Syndrome
- (2011) Bjørn Liaset et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
- (2010) Tim C. M. A. Schreuder et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Vitamin E and Cardiovascular Disease
- (2010) Adonis Saremi et al. AMERICAN JOURNAL OF THERAPEUTICS
- Epidemiology of Non-Alcoholic Fatty Liver Disease
- (2010) Stefano Bellentani et al. DIGESTIVE DISEASES
- Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism
- (2010) Gemma Brufau et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes
- (2010) Linda Vignozzi et al. Journal of Sexual Medicine
- FXR Regulates Liver Repair after CCl4-Induced Toxic Injury
- (2010) Zhipeng Meng et al. MOLECULAR ENDOCRINOLOGY
- The role of the gut microbiota in nonalcoholic fatty liver disease
- (2010) Ahmed Abu-Shanab et al. Nature Reviews Gastroenterology & Hepatology
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study
- (2009) Leon A Adams et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- What Is the Metabolic Role of Phosphoenolpyruvate Carboxykinase?
- (2009) Jianqi Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Bile acids: regulation of apoptosis by ursodeoxycholic acid
- (2009) Joana D. Amaral et al. JOURNAL OF LIPID RESEARCH
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
- (2009) Mary-Elizabeth Patti et al. Obesity
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Inhibition of ADRP prevents diet-induced insulin resistance
- (2008) Gladys M. Varela et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
- (2008) Nila Rafiq et al. Clinical Gastroenterology and Hepatology
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
- (2008) Stephen A. Harrison et al. HEPATOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Comparison of Strategies for Sustaining Weight LossThe Weight Loss Maintenance Randomized Controlled Trial
- (2008) Laura P. Svetkey JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
- (2008) Scott M. Lippman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
- Significance and Mechanism of CYP7a1 Gene Regulation during the Acute Phase of Liver Regeneration
- (2008) Lisheng Zhang et al. MOLECULAR ENDOCRINOLOGY
- Fatty Liver
- (2007) Anna Kotronen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now